申请人:Inoue Keisuke
公开号:US20050261349A1
公开(公告)日:2005-11-24
The present invention provides a medicine for preventing or treating a diabetes, which includes 2,2-dichloro-12-(4-chlorophenyl)-dodecanoic acid or a pharmacologically acceptable salt thereof, and glibenclamide as active ingredients. The present invention provides a method for preventing or treating a diabetes, which includes administering 2,2-dichloro-12-(4-chlorophenyl)-dodecanoic acid or a pharmacologically acceptable salt thereof, and glibenclamide to a patient suffering from or having a possibility of suffering from diabetes.
本发明提供了一种预防或治疗糖尿病的药物,其有效成分包括2,2-二氯-12-(4-氯苯基)-十二酸或其药理学上可接受的盐以及格列本脲。 本发明提供了一种预防或治疗糖尿病的方法,其中包括向患有或可能患有糖尿病的患者施用 2,2-二氯-12-(4-氯苯基)-十二酸或其药理学上可接受的盐以及格列本脲。